trending Market Intelligence /marketintelligence/en/news-insights/trending/cyq9ao3heachzay9d7qezq2 content esgSubNav
In This List

Orgenesis' stock to list on Nasdaq

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Orgenesis' stock to list on Nasdaq

Orgenesis Inc. said its common stock was approved for listing on the Nasdaq Capital Market.

The biopharmaceutical company's stock will start trading on the exchange on March 13, under its existing trading symbol ORGS.

Orgenesis currently trades on the OTCQB.